BioAlliance Pharma: Consolidated Accounts for the First Semester of 2011 and Recent Significant Key Events
PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), a company dedicated to specialty and orphan oncology products, today published its consolidated half-year accounts as of June 30, 2011 and presented the major key milestones recently achieved.